offers COVID-19 researchers free entry to world knowledge

RESEARCH TRIANGLE PARK — Contract analysis big IQVIA has launched a program that waives licensing and entry charges for accredited educational researchers as a part of its efforts to speed up analysis on how COVID-19 is impacting the healthcare business and associated therapy.

“The recent COVID-19 pandemic has created both immediate and long-term consequences for people and health systems around the world,” mentioned Murray Aitken, government director of the IQVIA Institute for Human Data Science.

Research Triangle Park-based firm launched the institute in October 2019 to supply firms and researchers world wide with entry to the corporate’s institutional data, analytics, know-how and knowledge. With this data, researchers have entry to data that can present perception into how well being programs world wide operate, how therapy is evolving and the way care is being delivered.

“IQVIA aspires to join the fight against the impact of COVID-19 by applying human data science to support research activities related to health system issues in collaboration with the world’s leading academic researchers,” added Aitken. “By waiving licensing and access fees, we can help accelerate evidence-based, COVID-19-related learning.”

The Human Data Science Research Collaborative, led by IQVIA Human Data Science, gives educational researchers entry to 2 of the corporate’s knowledge know-how platforms that may present perception into the challenges and alternatives created by COVID-19.

E360 is a Software as a Service, or SaaS, know-how platform. That’s a approach of delivering purposes over the Internet—as a service. It frees customers from putting in and sustaining software program. Instead, they’ll merely entry it through the Internet, avoiding advanced software program and {hardware} administration. E360 can be utilized to carry out scalable analytics from world, real-world knowledge. Using E360, researchers could have entry to nameless affected person knowledge from the U.S, France, Germany and the U.Okay.

IQVIA’s SMART platform gives knowledge that permits researchers to attract insights on how COVID-19 is impacting prescriptions, gross sales volumes, promotional and managed care market entry, in addition to medical machine and provide monitoring.

This knowledge inside these platforms will present wanted perception on how the healthcare business is reacting and adapting to the affect of COVID-19.

“We believe that the IQVIA technology platforms and analytics provide extraordinary resources for conducting collaborative research that can generate evidence and insights about the transformation of health systems in the COVID-19 era,” mentioned Aitken.

(c) North Carolina Biotechnology Center


Please enter your comment!
Please enter your name here